BlackRock Inc. raised its position in Liquidia Technologies Inc (NASDAQ:LQDA) by 137.4% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 833,030 shares of the company’s stock after purchasing an additional 482,139 shares during the period. BlackRock Inc. owned 4.47% of Liquidia Technologies worth $6,665,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Wells Fargo & Company MN lifted its holdings in Liquidia Technologies by 191.3% in the 2nd quarter. Wells Fargo & Company MN now owns 7,093 shares of the company’s stock valued at $57,000 after purchasing an additional 4,658 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Liquidia Technologies by 78.6% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 30,682 shares of the company’s stock valued at $246,000 after purchasing an additional 13,502 shares in the last quarter. Northern Trust Corp lifted its holdings in Liquidia Technologies by 17.6% in the 2nd quarter. Northern Trust Corp now owns 86,568 shares of the company’s stock valued at $693,000 after purchasing an additional 12,951 shares in the last quarter. Keel Point LLC purchased a new position in Liquidia Technologies in the 2nd quarter valued at $117,000. Finally, Parametric Portfolio Associates LLC lifted its holdings in Liquidia Technologies by 9.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 51,517 shares of the company’s stock valued at $412,000 after purchasing an additional 4,450 shares in the last quarter. Institutional investors own 58.82% of the company’s stock.
In other news, SVP Timothy Albury sold 6,762 shares of Liquidia Technologies stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $6.00, for a total transaction of $40,572.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. 4.30% of the stock is owned by insiders.
Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.32) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.57) by $0.25. The firm had revenue of $8.07 million during the quarter, compared to analysts’ expectations of $0.69 million. On average, equities analysts forecast that Liquidia Technologies Inc will post -2.43 earnings per share for the current year.
A number of research analysts have weighed in on the company. ValuEngine upgraded Liquidia Technologies from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. Zacks Investment Research lowered Liquidia Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, October 9th. Finally, Wedbush restated a “buy” rating and issued a $50.00 price objective on shares of Liquidia Technologies in a report on Friday, June 28th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $31.35.
Liquidia Technologies Company Profile
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension.
Featured Article: Systematic Risk
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.